Bioreactors Market to be Worth $39.96 Billion by 2031

Bioreactors Market Size, Share, Forecast, & Trends Analysis by Type (Continuous Stirred Tank, Photobioreactor), Bioprocess (Batch, Continuous), Usability (Reusable, Single-use), Scale (Pilot, Industrial), Cell Type, Application, User – Global Forecast to 2031

According to this latest publication from Meticulous Research®, the bioreactors market is projected to reach $39.96 billion by 2031, at a CAGR of 10.1% from 2024 to 2031. The growth of the bioreactors market is driven by several factors, including the capacity expansion of biopharmaceutical plants, the growing pharmaceutical market, rising pharmaceutical R&D expenditures, rising adoption of biosimilars, and growing adoption of single-use technologies in the pharmaceutical and biotechnology industries. Factors such as technological advancements in bioreactor technologies and rising adoption of personalized medicines and cell & gene therapies are opportunities for market growth. Risk of extractables and leachable (E&L) in biomanufacturing processes using single-use bioreactors, process scale-up limitations, the need to standardize single-use bioreactor designs, and environmental concerns related to the disposal of single-use bioreactors challenge the market growth. However, the complex development and manufacturing process of biopharmaceuticals and intensive capital requirements for biopharmaceutical production restrain the growth of the market.